Drugs / Islet
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00646724 | Jan 2008 → Jan 2012 | type 1 diabetes mellitus | Fuzhou General Hospital | Unknown | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00315614 | Dec 2000 → Dec 2010 | type 1 diabetes mellitus | University of Miami | Terminated | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT02655120 | Mar 2005 → May 2017 | avascular necrosis | University Hospital, Lille | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | islet | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00646724 ↗ |
| Known as | Bone Marrow | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02655120 ↗ |
| Modality | Cell therapy | “by islet cell transplantation.” NCT00315614 ↗ |